PET and SPECT of Neurobiological Systems
PET and SPECT of Neurobiological Systems
复制标题
DOI:
10.2967/jnumed.115.164616
复制
发表时间:
2015-08
期刊:
影响因子:
--
通讯作者:
Hongyoon Choi;D. Lee
中科院分区:
文献类型:
--
作者:
Hongyoon Choi;D. Lee
intensity that can reflect microvascular injuries and thus explain dementia or cognitive impairment. Readers are also presented with the cerebrovascular risk factors for Alzheimer disease, as well as the tantalizing topic of the differential contribution of vascular and degenerative processes to a patient’s dementia. Readers will be led to ponder the sensitivity of this topic because of the fuzzy boundary between Alzheimer disease and subcortical vascular dementia. We might refine the PET and SPECT studies introduced in this book for possible use in discriminating or characterizing various conditions. A few types of receptor PET are introduced, including imaging of the nicotinic acetylcholine receptor system and of inflammation in dementia. Considering the importance of inflammation in neurodegenerative and neuropsychiatric illnesses, the emphasis on neuroinflammation PET of microglial activation is appropriate. However, in another chapter, use of the different name of translocator protein PET/SPECT to describe the same technique for multiple sclerosis is annoying. In contrast, the decision to deal with carotid artery imaging of inflammation and atherosclerosis separately in 2 chapters is appealing. The book covers the most common study for imaging of carotid vulnerability in the clinic—18F-FDG PET—as well as introducing experimental or preclinical imaging of lipid accumulation, imaging of thrombosis, and angiogenesis imaging related to carotid atherosclerotic plaque. These topics seem sufficient to attract physicians’ interest. The epilepsy studies in this book focus on novel PET ligands showing g-aminobutyric acid–ergic transmission, serotonergic or opioid transmission, and P-glycoprotein 1. The listed functional PET studies have interesting findings in disclosing the pathophysiology of epilepsy and promise the future use of PET and SPECT in the development of antiepileptic drugs.